Thoresen; Lars

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thoresen; Lars.The latest application filed is for "cannabinoid receptor modulators".

Company Profile

4.13.26

Thoresen; Lars - San Diego CA
Thoresen; Lars - Venice CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cannabinoid Receptor Modulators App 20220306586 - Jones; Robert M. ; et al.	2022-09-29
Cannabinoid Receptor Modulators App 20220241274 - Thatte; Jayant ; et al.	2022-08-04
Cannabinoid receptor modulators Grant 11,214,548 - Jones , et al. January 4, 2	2022-01-04
Cannabinoid Receptor Modulators App 20210188781 - Jones; Robert M. ; et al.	2021-06-24
Cannabinoid Receptor Modulators App 20210060040 - Thatte; Jayant ; et al.	2021-03-04
Cannabinoid receptor modulators Grant 10,632,134 - Thatte , et al.	2020-04-28
Cannabinoid Receptor Modulators App 20200069681 - Thatte; Jayant ; et al.	2020-03-05
Cannabinoid Receptor Modulators App 20200017448 - Jones; Robert M. ; et al.	2020-01-16
Cannabinoid Receptor Modulators App 20180354907 - Jones; Robert M. ; et al.	2018-12-13
Cannabinoid Receptor Modulators App 20180280386 - Thatte; Jayant ; et al.	2018-10-04
Cannabinoid receptor modulators Grant 9,944,606 - Jones , et al. April 17, 2	2018-04-17
Cannabinoid receptor modulators Grant 9,867,822 - Thatte , et al. January 16, 2	2018-01-16
Cannabinoid Receptor Modulators App 20170304327 - Thatte; Jayant ; et al.	2017-10-26
Cannabinoid Receptor Modulators App 20170143704 - Thatte; Jayant ; et al.	2017-05-25
Cannabinoid receptor modulators Grant 9,597,340 - Thatte , et al. March 21, 2	2017-03-21
Cannabinoid receptor modulators Grant 9,492,447 - Thatte , et al. November 15, 2	2016-11-15
Cannabinoid Receptor Modulators App 20160271127 - Thatte; Jayant ; et al.	2016-09-22
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20150336966 - Jones; Robert M. ; et al.	2015-11-26
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders Grant 9,108,969 - Jones , et al. August 18, 2	2015-08-18
Cannabinoid Receptor Modulators App 20150126477 - Thatte; Jayant ; et al.	2015-05-07
Cannabinoid Receptor Modulators App 20140206649 - Thatte; Jayant ; et al.	2014-07-24
Cannabinoid receptor modulators Grant 8,778,950 - Jones , et al. July 15, 2	2014-07-15
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto App 20140018371 - Jones; Robert M. ; et al.	2014-01-16
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20130184307 - Jones; Robert M. ; et al.	2013-07-18
Cannabinoid Receptor Modulators App 20130165412 - Jones; Robert M. ; et al.	2013-06-27
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders Grant 8,415,484 - Jones , et al. April 9, 2	2013-04-09
Cannabinoid Receptor Modulators App 20120214766 - Jones; Robert M. ; et al.	2012-08-23
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20110160243 - Jones; Robert M. ; et al.	2011-06-30
Dihydro-1h-pyrrolo[1,2-a]indol-1-yl Carboxylic Acid Derivatives Which Act As S1p1 Agonists App 20100292233 - Jones; Robert M. ; et al.	2010-11-18
Tetrahydrocyclopenta[b]indol-3-yl Carboxylic Acid Derivatives Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20100273806 - Jones; Robert M. ; et al.	2010-10-28
2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases App 20080070867 - Cheruvallath; Zacharia S. ; et al.	2008-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.